A Two-Part Study to Evaluate the Safety, Tolerability, Pharmacodynamics And Pharmacokinetics of TRV734 in Healthy Adult Male and Female Subjects

Trial Profile

A Two-Part Study to Evaluate the Safety, Tolerability, Pharmacodynamics And Pharmacokinetics of TRV734 in Healthy Adult Male and Female Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Sep 2015

At a glance

  • Drugs TRV 734 (Primary) ; Oxycodone
  • Indications Acute pain; Pain
  • Focus Adverse reactions
  • Sponsors Trevena
  • Most Recent Events

    • 08 Sep 2015 Data from this trial will be presented at the PAINWeek, the National Conference on Pain for Frontline Practitioners 2015, according to a Trevena medial release.
    • 09 Feb 2015 Results published in a Trevena media release.
    • 04 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top